2024/8/2 投資ネタ

UG
#ISRG Redburn-Atlantic Upgrades Intuitive Surgical to Buy, Raises PT to $510 from $380
-長期的にﾛﾎﾞｯﾄ支援手術は回復手術などを駆逐する
-投資一巡のメドがつき、供給も増える
#AA upgraded to Peer Perform from Underperform at Wolfe Research
-ﾊﾞﾘｭｴｰｼｮﾝ
--ｱﾙﾐ価格の下落余地が限定的
#QCOM upgraded to Buy from Hold at DZ Bank
#TEAM upgraded to Buy from Neutral at Goldman Sachs
-ｸﾗｳﾄﾞ移行の最も厳しい部分を終了
-ｸﾗｳﾄﾞ成長/ﾃﾞｰﾀｾﾝﾀｰ移行/ﾏｰｼﾞﾝについても保守的ｶﾞｲﾀﾞﾝｽ

DG
#AMZN downgraded to Market Perform from Outperform at Itau BBA at 186
#MS Wells downgrades Morgan Stanley to Underweight on premium valuation at 95
-ﾊﾞﾘｭｴｰｼｮﾝが高い
--WMのinflow鈍化
--NIIの鈍化/fee収益の鈍化
#LULU downgraded to Neutral from Buy at Goldman Sachs at 286
-新商品の撤回など、新商品に苦戦
-販促も増加
#INTC downgraded to Market Perform from Outperform at Raymond James
#INTC downgraded to Reduce from Hold at HSBC
#INTC downgraded to Underperform from Neutral at BofA at 23
#INTC downgraded to Hold from Buy at Benchmark
-Q3見通しが弱すぎる、特にﾏｰｼﾞﾝ
--ﾏｰｼﾞﾝの逆風は2025 or 2026まで続く
#ARE downgraded to Hold from Buy at Jefferies
-3ﾃﾅﾝﾄが2025に退去
-ﾀﾞｳﾝﾀｲﾑが12-24か月
-NYの建物売却で追加ｺｽﾄ発生
#SO downgraded to Perform from Outperform at Wolfe Research
-ﾊﾞﾘｭｴｰｼｮﾝ
--ﾃﾞｰﾀｾﾝﾀｰによる需要増に対してはﾎﾟｼﾞﾃｨﾌﾞ
#TEAM downgraded to Neutral from Outperform at Baird at 175
-FY25ｶﾞｲﾀﾞﾝｽが予想以下
-営業組織の変更で不透明性悪化
#MCHP downgraded to Neutral from Buy at BofA at 90
-ｼｸﾘｶﾙの逆風が推移四半期継続
-2025の回復も在庫過多の状況を鑑みると予想以下
#CROX downgraded to Outperform from Strong Buy at Raymond James at 164

earnings
#LIN
#XOM
〇:Q2売上・EPS・原油生産量
×:精製量
#CVX
〇:Q2売上
×:Q2EPS
-生産量+11%
--ﾊﾟｰﾐｱﾝの生産過去最高

個別株
#MU #HXSCL #SSNLF U.S. weighs unilateral resrtictions on China access to AI chips, Bloomberg says

TP関連
#AAPL price target raised by several firms
-ｻｰﾋﾞｽ/iphoneが堅調
-買替ｻｲｸﾙ本格化間近
#AAPL price target lowered to $186 from $187 at Barclays
-中国ﾘｽｸ
-ｻｰﾋﾞｽに対する規制ﾘｽｸ
-AIの特徴と導入のﾀｲﾐﾝｸﾞが不透明でiphone16も懸念
#AMZN price target raised by several firms
-AWS堅調、小売も堅調
-CAPEX増、減価償却ｻｲｸﾙ懸念
--経営のﾘﾀｰﾝに対する自信で相殺
#AMZN PT lowered by several firms
-Q2の営業利益はｶﾞｲﾀﾞﾝｽ上限超え
-AWSが特に強く、+19%に再加速
-1Hの投資は予想以上で、2HはAWSの為に投資増
-Q3営業利益見通しが予想以下
-小売り関連はmix
-広告も+20%で予想以下
#INTC PT lowered by several firms
-2Hの見通しがすべて失望
--ﾏｸﾛは重石だが、それ以上にｲﾝﾃﾙ固有の要因の弱さ
--在庫も重石
-ﾘｽﾄﾗ計画も競争環境を考えると不十分
#BKNG price target lowered by several firms
-2024の予約金額が引下げ
--航空代下落が重石
-3Qは予約者数が鈍化
--欧州鈍化
#CI price target raised to $405 from $393 at Barclays
-2024のｺｽﾄのﾄﾚﾝﾄﾞに変化無し
#CROX price target lowered to $164 from $169 at Barclays
-Q3見通しが軟調
--投資増が重石
#DASH price target raised by several firms
-2HのEBITDAﾏｰｼﾞﾝｶﾞｲﾀﾞﾝｽ引上げ
--ﾚｽﾄﾗﾝ需要減少懸念を打ち消し
-6月が最も堅調
#FSLR price target raised to $290 from $280 at Barclays

#WEN price target lowered to $19 from $20 at Stephens
-SSS/ﾏｰｼﾞﾝ/新店舗が米・海外共に弱い
--客足不調
#CTVA price target lowered to $62 from $66 at KeyBanc
-農薬等の価格設定や種子価格の不透明感
-農薬市場は回復期にあり、販売量も2025以降回復見込み
#SHAK price target raised by several firms
-好調なQ2決算
--SSS堅調/平均ﾕﾆｯﾄﾎﾞﾘｭｰﾑの増加
#ROKU price target lowered to $80 from $90 at JPMorgan
-Q2ﾋﾞｰﾄ/Q3ｶﾞｲﾀﾞﾝｽい予想通り
-3Qに成長を示せるかが重要
#SNAP price target lowered by several firms
-DRの改善がいまいち
-1Qのﾓﾒﾝﾀﾑ喪失
--一般消費財の広告需要鈍化/Q3にも継続
#HSY price target raised to $195 from $188 at Citi
-ネガティブ材料織り込み済み
#W price target lowered to $70 from $85 at Citi
-Q3の売上見通しが厳しいまま
#NET price target raised to $100 from $94 at Baird
-Q2は好決算
-ｶﾞｲﾀﾞﾝｽも引上げ
--大顧客の需要強い

マクロ・債券
(米国)

(欧州)
FRENCH INDUSTRIAL PRODUCTION MOM ACTUAL 0.8% (FORECAST 1%, PREVIOUS -2.1%)
ITALIAN RETAIL SALES MOM ACTUAL -0.2% (FORECAST -, PREVIOUS 0.40%)
(その他)

コモ